RT @Myeloma_Doc: #Myeloma Paper of the Day: Pre-treatment w/ iberdomide & dex in Vk*MYC mouse model reshapes bone marrow T cell compartment….

RT @hhashmi87: Not all MRD resurgent pts are the same; some have 'immune' MRD negativity (naive PB T cell phenotype) that predicts long ter….

RT @Myeloma_Doc: #Myeloma Paper of the Day: Immune-MRD status informs tumor-MRD outcome prognostication in myeloma pts on Len maintenance;….

RT @oncodaily: @FrancescoMaura4 @NatureGenet @HDMyeloma @SylvesterCancer @MayoClinic @MSKCancerCenter @MSK_DeptOfMed We would like to infor….

RT @BenDiamondMD: Thank you for the great submission process and beautiful cover art! Link to tweetorial here:

Wonderful graphical art of our work investigating the mutagenic impact of radiotherapy in hematological malignancies. @MSKCancerCenter @MoffittNews @SylvesterCancer! Thanks @BCD_AACR for the great editorial support!.

Thanks to @SafiaDanovi for the editorial process 🙏! An among the many collaborators a special thanks to @RaabMarc, @MayoMyeloma, @szusmani @MKaddouraMD, Alexandra Poos and my friend Niels Weinhold!! 🇺🇸🇩🇪💪.

We interrogated 421 #WGS from @MSKCancerCenter and @HDMyeloma to generate several cool new findings and develop interesting temporal analyses. This paper further highlight the power of #WGS for myeloma. Summary of the key findings can be found here:

Here is the link to access the paper:

Excited to share our new paper, out today on @NatureGenet where we use 421 #WGS to reconstruct the evolutionary history of multiple myeloma #mmsm (🔥🔥). Great collaboration with @HDMyeloma @SylvesterCancer @MayoClinic @MSKCancerCenter @MSK_DeptOfMed ⁦.

RT @hhashmi87: This was an excellent state-of-the-art meeting focused solely on GPRC5d in #MMSM with some great presentations, debates, and….

RT @GreenLymphoLab: Data sharing for publication: We need a better solution than dbGAP and EGA. They are over-burdened, but waiting 3 month….

RT @DrKTakahashi: 🚨 New paper in @NatureGenet !.How does cancer chemotherapy reshape the HSC landscape and drive the evolution of therapy-r….

RT @CancerGrand: Important new research from one of our Cancer Grand Challenge’s teams could help to improve cancer treatment choices in th….

RT @BloodPortfolio: Today, patients with multiple myeloma, and those with precursor conditions, are prognosticated by measuring tumor burde….

The lab and the ⁦⁦⁩myeloma team at ⁦@MSKCancerCenter⁩ are very excited to welcome my friend and long term collaborator ⁦@BachisioZic⁩ and to host the rising star ⁦@hollyleeYJ⁩ ⁩for the rest of 2025 as visiting scientist @szusmani⁩ #mmsm

It was fun to work with @RossFirestone in writing this editorial for @BloodPortfolio #Blood "More than myeloma: the trouble with “normal” plasma cells", on the recent article from @nickbolli @matteoclaudio84 @MSKCancerCenter @MSK_DeptOfMed #mmsm.

RT @GreenLymphoLab: Lymphoma Microenvironment Archetype Profiles (LymphoMAPs). Just presented by @dgermain21 at #18icml @icmlugano, now ava….

RT @oncodaily: Biallelic Antigen Escape is a Mechanism of Resistance to Anti-CD38 Antibodies in MM - @FrancescoMaura4 . @BloodPortfolio @Be….